(Q36136402)

12 August 2017

Weekly doxorubicin and continuous infusional 5-fluorouracil for advanced breast cancer (English)

1 reference

12 August 2017

1 reference

1 reference

Gabra H

1 reference

12 August 2017

Cameron DA

1 reference

12 August 2017

Lee LE

1 reference

12 August 2017

Mackay J

1 reference

12 August 2017

Leonard RC

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 December 1996

1 reference

British Journal of Cancer

12 August 2017

1 reference

12 August 2017

1 reference

12 August 2017

1 reference

12 August 2017

2008-2012

1 reference

Chemotherapy of advanced breast cancer: outcome and prognostic factors

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074814

The importance of dose intensity in chemotherapy of metastatic breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074814

The importance of dose intensity in the outcome of chemotherapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074814

Weekly epirubicin for breast cancer with liver metastases and abnormal liver biochemistry

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074814

Assessment of response to therapy in advanced breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074814

Experience with the use of adriamycin in combination with other anticancer agents using a weekly schedule, with particular reference to lack of cardiac toxicity

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074814

Cardiotoxicity Associated With High-Dose Cyclophosphamide Therapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074814

Reduced cardiotoxicity of doxorubicin delivered on a weekly schedule. Assessment by endomyocardial biopsy

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074814

Comparative pharmacokinetics of doxorubicin given by three different schedules with equal dose intensity in patients with breast cancer

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074814

Doxorubicin in advanced breast cancer: influence of schedule on response, survival and quality of life

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074814

Assessment of response to therapy in advanced breast cancer (an amendment)

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074814

A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074814

Treatment and survival on advanced breast cancer

23 September 2018

1 reference

12 December 2020

Increased therapeutic index of weekly doxorubicin in the therapy of non-small cell lung cancer: a prospective, randomized study

1 reference

12 December 2020

Continuous 5-fluorouracil infusion in refractory carcinoma of the breast

1 reference

12 December 2020

The Duke AFM Program. Intensive induction chemotherapy for metastatic breast cancer

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1996.668

1 reference

Dimensions Publication ID

12 August 2017

1003048939

0 references

Fatcat ID

release_6eb3efzdzna3lbzjogpbrlwggq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6eb3efzdzna3lbzjogpbrlwggq

24 November 2022

mapped directly with Wikidata item

1 reference

12 August 2017

PubMed publication ID

8980405

1 reference